✦ LIBER ✦

Insulin in aging and cancer: antidiabetic drug diabenol as geroprotector and anticarcinogen

✍ Scribed by Irina G. Popovich; Mark A. Zabezhinski; Peter A. Egormin; Margarita L. Tyndyk; Ivan V. Anikin; Alexander A. Spasov; Anna V. Semenchenko; Anatoly I. Yashin; Vladimir N. Anisimov

Book ID: 116306866
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 168 KB
Volume: 37
Category: Article
ISSN: 1357-2725
DOI: 10.1016/j.biocel.2004.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central and Peripheral Effects of Insuli

Central and Peripheral Effects of Insulin/IGF-1 Signaling in Aging and Cancer: Antidiabetic Drugs as Geroprotectors and Anticarcinogens

✍ VLADIMIR N. ANISIMOV; LEV M. BERSTEIN; IRINA G. POPOVICH; MARK A. ZABEZHINSKI; P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

[Cancer Treatment and Research] Advances

[Cancer Treatment and Research] Advances in Nutrition and Cancer Volume 159 || New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent

✍ Zappia, Vincenzo; Panico, Salvatore; Russo, Gian Luigi; Budillon, Alfredo; Della 📂 Article 📅 2013 🏛 Springer Berlin Heidelberg ⚖ 426 KB

Age disparity between a cancer populatio

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan

✍ Akiko Hori; Taro Shibata; Masahiro Kami; Eiji Kusumi; Hiroto Narimatsu; Yukiko K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract ## BACKGROUND. Underrepresentation of older patients in cancer clinical trials has been reported previously. ## METHODS. To evaluate disparities in age between actual cancer patients and those enrolled in clinical trials, the authors examined all the review reports of the Pharmaceuti

Intelligent drug design come of age: STI

Intelligent drug design come of age: STI571 as the start a of a new era in cancer research and treatment

✍ Juan Carlos Lacal 📂 Article 📅 2001 🏛 Springer Milan 🌐 Spanish ⚖ 26 KB